Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Heart mesh alleviates stubborn angina in 1st US procedure

Cardiologists at Henry Ford Hospital in Detroit have successfully performed the country’s first implantation of the Neovasc Reducer—a stainless steel, hourglass-shaped heart mesh designed to alleviate difficult angina—the hospital announced in a statement Sept. 26.

Thumbnail

23 Arkansas hospitals unite to reduce impact of MI in the state

Twenty-three hospitals from across Arkansas have joined the Arkansas Heart Attack Registry (AHAR), a collaborative effort to reduce the impact of myocardial infarctions in the state, THV 11 reported this week.

How one stem cell study is rewriting the way scientists look at blood vessels

Stem cells in the embryo, previously thought to mature into only red blood or immune system cells, have another function, according to new research out of University College London. They can differentiate into endothelial cells, too, and could help in the growth of blood vessels in developing fetuses.

Thumbnail

‘A new paradigm’: Vascepa achieves 25% CV risk reduction in cardiac patients

Biopharmaceutical company Amarin this week announced the topline results of its REDUCE-IT trial, a global study that achieved 25 percent cardiovascular risk reduction in a population of 8,179 statin-treated adults with the daily use of Vascepa, also known as icosapent ethyl.

Thumbnail

Researchers solidify link between mitral valve prolapse, sudden cardiac death

Mitral valve prolapse (MVP)—a common condition that’s rarely serious—might boost heart patients’ risk for sudden cardiac death (SCD), researchers reported in the BMJ journal Heart this week.

Thumbnail

TCT.18: Ultrasound-guided DES implantation yields better outcomes than angiography-guided surgery

Intravascular ultrasound (IVUS)-guided stent implantation offers improved clinical outcomes for heart patients over a traditional angiography-guided approach, researchers from China reported at this week’s Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Diego, California.

Thumbnail

Eluvia vascular stent approved by FDA following IMPERIAL

The Eluvia drug-eluting vascular stent system has been approved by the FDA, device maker Boston Scientific announced Sept. 24—just two days after results from the IMPERIAL trial were presented at the Transcatheter Cardiovascular Therapeutics 2018 meeting.

Thumbnail

TCT.18: ReCre8 finds polymer-free stent safe, effective for clinical use

A novel, polymer-free amphilius-eluting stent known as the “Cre8” was proven noninferior to the latest-generation permanent polymer drug-eluting stent in the first large-scale trial of its kind, according to research presented at the Cardiovascular Research Foundation’s 30th annual TCT conference in San Diego.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.